Mylan Nabs Partial Win On EpiPen Claims, Still Faces Trial
By Matthew Perlman · June 25, 2021, 7:06 PM EDT
Mylan will not face racketeering claims or claims over its rebates for the EpiPen in a scheduled September trial in Kansas federal court, but a jury will still hear allegations from...
To view the full article, register now.